Wing Tech Inc.
9916 Newhall Rd.
Potomac, MD 20854
+1 301 660 8000
Wing Tech Inc.
101 Jefferson Dr.
Menlo Park, CA 94025
+1 650 943 3000
Wingtec GmbH
Im Rosengärtle 14
Karlsruhe, DE
+49 721 56044 900
Wing Tech Inc.
9916 Newhall Rd.
Potomac, MD 20854
+1 301 660 8000
Wing Tech Inc.
101 Jefferson Dr.
Menlo Park, CA 94025
+1 650 943 3000
Wingtec GmbH
Im Rosengärtle 14
Karlsruhe, DE
+49 721 56044 900
Helping life sciences innovators navigate complexity and realize opportunities
Get Started!Publications
Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study
Pietzsch JB, Geisler BP, Garner AM, Ryschon AM, Gray WA, Fujihara M, Schneider PA. Clinical and e...
Economics of drug-coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV Access Trial
Chun HJ, Cao KN, Haruguchi H, Choi H, Yoshikawa M, Holden A, Pietzsch JB. Economics of drug-coate...
pDVI Cost-Effectiveness Study Published
May 28, 2021: Wing Tech analysis “Cost-Effectiveness of Percutaneous Deep Vein Arterialization ...
Wing Tech is an international technology and management consulting firm specializing in health-economic evidence development and strategic analysis for innovators in the global life sciences and medical technology sectors.
With more than two decades of experience, Wing Tech combines rigorous analytical methodologies with deep clinical and industry expertise to support evidence-based decision-making throughout the technology lifecycle. The firm serves a diverse client base, including Fortune 500 medical technology companies, leading research institutions, investors, and emerging life sciences ventures.
Wing Tech’s expertise and project experience span a broad range of clinical indications, diagnostic and therapeutic technologies, and healthcare systems worldwide.
Wing Tech applies rigorous analytical methodologies to generate evidence and inform strategic decision-making throughout the lifecycle of life sciences innovation.
Wing Tech’s peer-reviewed publications and scientific conference presentations contribute evidence and insights to inform clinical, economic, and strategic decision-making.
A health-economic analysis found transcatheter aortic valve replacement (TAVR) to be a cost-effective alternative to surgical valve replacement among patients at low surgical risk in the UK healthcare system.
Wing Tech research lead Anne Ryschon, MA presented the findings of an exploratory analysis, co-authored with Dr. Giovanni De Maria (Univ. of Oxford), at ISPOR Europe, Vienna, Austria. Read More: ISPORE Europe 26 - Ryschon - EE310
Dr. Sheetal Patel, Medical Director of Fetal Cardiology at Lurie Children’s Hospital of Chicago, presented findings from a collaborative research study on AI-assisted detection of congenital heart disease at the 2026 Phoenix Children’s Fetal C...
A health-economic evaluation of transvenous diaphragm neurostimulation (tDNS) for ventilator weaning was published in Critical Care Medicine. The study, co-authored by Dr. Joseph Shrager of Stanford University, a co-principal investigator of the R...
A health-economic evaluation of the SetPoint System®, a neuroimmune modulation device for moderate-to-severe rheumatoid arthritis, was published in the Journal of Medical Economics. The study draws on economic modeling conducted by Wing Tech. ...
May 3, 2025, Washington DC: Study lead author Dr. Sameh Sayfo (Baylor Scott & White Legacy Heart Center, Plano, TX) presented on the findings of a Wing Tech-led systematic search and meta-analysis of outcomes of endovascular treatment of long ...
May 2025, Paris, France: Prof. Andrew Sharp (University College Dublin, Ireland) will present “Cost-effectiveness of radiofrequency renal denervation in five European countries” at a session at EuroPCR 2025, the world-leading course in interve...